Clinical Trial Update: Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating sugammadex to reverse rocuronium-induced neuromuscular blockade under sevoflurane anesthesia in infants with brain cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer

Drugs mentioned

• Rocuronium (rocuronium bromide)
• Sevoflurane (Sevoflurane)
• Sugammadex (sugammadex)

Snippet

Sponsor: Baskent University | Conditions: Brain Cancer | Phase 4 | Status: COMPLETED